Bharat Immunological & Biological Corporation Ltd
Bharat Immunological & Biological Corporation Ltd (524663): company summary
Bharat Immunological & Biological Corporation Ltd (524663) is a micro-cap Healthcare company valued at ₹69 crore operating in Pharmaceuticals on the NSE and BSE.
Bharat Immunological & Biological Corporation Ltd (524663) is a micro-cap Healthcare company valued at ₹69 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Return on equity stands at -17.7%.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at -2.13 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
We do not have enough data on this company to score it — only 2 of 5 measures could be assessed. Rather than publish a number built on that, we are showing none.
DocStoX score
Low confidenceOnly 2 of 5 measures could be assessed — too little to score this company honestly.
At a glance
Key highlights
- Loss-making in some of the last 4 years
- Quality is weak (0.0/10)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Bharat Immunological & Biological Corporation Ltd’s valuation
Free deep-dive tools · no sign-up
Bharat Immunological & Biological Corporation Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Bharat Immunological & Biological Corporation Ltd with peers
Related tools & concepts
Value Bharat Immunological & Biological Corporation Ltd with the ratios and calculators DocStoX uses in its analysis.

